CTRI/2022/03/041064尚未招募未知
Efficacy of Rho Kinase Inhibitor Ripasudil for the management of Corneal edema following cataract surgery
Office of Director General Armed Forces Medical Services0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Patients who develop immediate corneal edema, that is, corneal edema observed on day one after undergoing cataract surgery would be initially enrolled in the study.
排除标准
- •Pre-operative factors
- •Eyes with advanced retinal pathology, corneal pathology such as dystrophies, degenerations or prior corneal trauma with residual scarring
- •Chronic diagnosed glaucoma or ocular hypertension at baseline examination
- •Use of any topical medication that is toxic to corneal endothelium
- •Diabetes mellitus
- •Immunocompromised states
- •Postoperative complications
- •Endophthalmitis, toxic anterior segment syndrome, postoperative rise in IOP (to >21mm Hg)
研究者
相似试验
尚未招募
不适用
To check efficacy of ripasudil in management of primary open angle glaucomaCTRI/2021/05/033754Dr Sowparnika A B
已完成
2 期
Inhibition of Rho Kinase (ROCK) with Fasudil as disease-modifying treatment for ALSAmyotrophic lateral sclerosis (ALS)G12.2Motor neuron diseaseDRKS00013948Georg-August-Universität Göttingen, Stiftung Öffentlichen Rechts, Universitätsmedizin Göttingen120
进行中（未招募）
1 期
Inhibition of Rho Kinase (ROCK) with Fasudil as disease-modifying treatment for ALSAmyotrophic lateral sclerosisMedDRA version: 21.1Level: PTClassification code 10002026Term: Amyotrophic lateral sclerosisSystem Organ Class: 10029205 - Nervous system disordersEUCTR2017-003676-31-FRGeorg-August-Universität Göttingen120
尚未招募
3 期
Efficacy of Rho-Kinase inhibitor in Post-operative Striate KeratopathyCTRI/2024/04/065348BLDE UNIVERSITY
已完成
不适用
One-year Efficacy of Adjunctive Use of Ripasudil, a Rho-Kinase Inhibitor, in Patients with Glaucoma Inadequately Controlled under Maximum Medical TherapyPrymary open angle glaucomaJPRN-UMIN000026228Department of Ophthalmology and Micro-technology, Yokohama City University School of Medicine, Yokohama, Japan50